Instalab
logoInstalab

GGT

Blood Test
Spot liver and bile-flow strain that routine panels may miss, especially when alcohol or fatty liver is part of the story.
4.9 (2,777 reviews)
Tested by Quest, Access Medical or Boston Heart
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home or at 2,000+ patient service centers
Get results
Explained with clear next steps, no medical jargon

Should you take a GGT test?

This test is most useful if any of these apply to you.

Watching Your Liver
See liver or bile-flow strain that a standard metabolic panel can miss.
Rethinking How Much You Drink
Track whether cutting back is easing liver stress; GGT often falls over weeks with abstinence.
Carrying Extra Weight Around the Middle
See whether belly weight is paired with an enzyme pattern that often tracks metabolic fatty liver.
Building a Fuller Heart Risk Picture
Add a marker linked to cardiovascular death beyond cholesterol and blood pressure, with modest prediction gains.

About GGT

If a routine blood panel has ever come back clean, GGT may still not have been measured. A standard metabolic panel usually includes ALT, AST, alkaline phosphatase, and bilirubin, but not GGT. Some liver panels include it. Many don't.

That gap matters. GGT has a narrow use and a wider one. Narrowly, it helps interpret liver and bile-duct patterns. In very large cohorts, higher serum GGT also predicts higher risk of cardiovascular death, cancer, liver outcomes, and death from any cause. That doesn't make it a diagnosis, and liver guidelines advise against using GGT on its own to screen for disease when the rest of your liver chemistry is normal. It makes it a stress marker to read with the rest of the panel.

What It Actually Measures

GGT is gamma-glutamyl transferase. It is an enzyme anchored to the outer surface of many cells. It helps recycle glutathione. Glutathione is one of the body's main internal antioxidants. Antioxidants help limit chemical wear inside cells.

When cells are dealing with alcohol, excess liver fat, inflammation, or toxins, they can make more GGT. More of it then shows up in the blood. Most labs measure GGT activity in serum from a blood draw. Serum is the liquid part of blood after it clots.

The enzyme is most concentrated in the liver and the cells lining the bile ducts. Bile ducts are the small tubes that drain bile from the liver. That is why GGT often rises strongly when bile flow is blocked. A result tells you that cells somewhere are stressed or damaged; it does not, on its own, tell you where or why.

Liver and Bile Duct Disease

This is the enzyme's classic use. It often rises with fatty liver, hepatitis, cirrhosis, and bile-flow problems. It is sensitive, especially when bile drainage is blocked, but it is not specific. Some people with liver disease can still have a normal GGT, and many non-liver factors can raise it.

Its sharpest single use is to settle where a high alkaline phosphatase is coming from. Alkaline phosphatase rises from both liver and bone. Bone disease usually does not raise GGT. If both alkaline phosphatase and GGT are up, the source is more likely liver or bile ducts. If alkaline phosphatase is up and GGT is normal, bone becomes more likely.

Alcohol

Sustained heavy drinking often raises GGT more than other routine liver tests, and the rise tracks how much you drink. In a Finnish study of nearly 14,000 people, heavy-drinking men and women were about six times as likely to have an abnormal result as non-drinkers. The jump became clear above roughly 14 drinks a week for men and 7 for women.

Two things temper this. A normal result does not clear you of heavy drinking, especially if you are young: many young heavy drinkers show no rise at all. And a high result is not proof of drinking, since weight, diabetes, and medications push it up too. With real abstinence, it takes about two to three weeks for levels to fall by half. That makes repeat readings useful for tracking a change rather than judging one snapshot.

Heart Disease and Early Death

This is the enzyme's wider use. Pooling nine studies and more than 527,000 people, each 10 U/L step up in GGT came with about a 10 percent higher risk of dying from cardiovascular disease. People with the highest levels had roughly 60 percent higher risk than those with the lowest. Active GGT has also been found inside human artery plaques. The signal is weaker once every risk factor is accounted for: in some datasets the fully adjusted cardiovascular link loses statistical significance, and it tends to be stronger for heart failure and liver outcomes than for heart attack.

The link to death from any cause is just as consistent. Across studies covering more than 9 million people, those in the top third had about 60 percent higher risk of dying than those in the bottom third. In a Korean study of 9.7 million adults with no viral hepatitis or cirrhosis, the highest third had about a third higher risk of death over eight years. These associations held after accounting for age, sex, smoking, alcohol, weight, blood pressure, diabetes, and cholesterol.

Risk is not a cliff at the lab cutoff. In the UK Biobank, higher values within commonly used reference ranges were already tied to higher liver-related, cardiovascular, and all-cause mortality. Adding GGT to a standard European cardiovascular mortality score correctly moved just over 1 in 100 people who later died from cardiovascular disease into a higher-risk group. Useful, but modest, and the same authors cautioned that this is not enough to justify seeking out GGT on its own as a disease predictor.

Cancer

Higher levels are linked with modestly higher cancer risk overall and a sharper signal for cancers of the digestive tract. Across 14 cohort studies and 1.79 million people, the top third had about a third higher overall cancer risk than the bottom third, and nearly double the risk for digestive organ cancers. The strongest single link is liver cancer: in a Korean study, men in the highest fifth had close to seven times the liver cancer risk of the lowest fifth. Women showed a similarly strong liver-cancer association.

Why a Liver Enzyme Predicts So Much

Why would a liver enzyme forecast heart attacks and cancer? Usually not because the liver is quietly failing. Higher GGT often travels with alcohol exposure, liver fat, diabetes risk, and oxidative stress. Oxidative stress means cells are dealing with too much chemical wear. Those same processes can damage arteries and raise cancer risk.

Some genetic analyses suggest GGT is more often a marker of that burden than a direct cause of disease. So treat it as a signal to look for what is driving it, not as the problem to fix on its own.

Why One Reading Is Not Enough

A single number can mislead in both directions. In healthy people, the same person's serum GGT varies by about 9 percent from natural week-to-week variation alone. Levels also shift with weight, drinking, medication exposure, and whether you have eaten. Your own trend is often more informative than one comparison with a wide population range.

One useful fact: GGT is steadier than its liver-test cousins. When people with an initially high value were retested about two and a half weeks later, only 12 percent had normalized, compared with 31 percent for ALT and 36 percent for AST. A high result is less likely to be a fluke than some other liver tests, but it still deserves a second look before you draw conclusions.

What an Unexpected Result Should Make You Do

A high reading is a starting point, not a diagnosis. The next move depends on what surrounds it. Order or review the rest of the liver panel: alkaline phosphatase, ALT, AST, and bilirubin. If alkaline phosphatase is also up, the picture points to the liver or bile ducts and often warrants an ultrasound. If ALT and AST are up together, that points to injury in liver cells.

If the liver panel is otherwise clean but GGT is high alongside a large waist, high triglycerides, or high blood sugar, fatty liver is a common explanation. The finding is a prompt to take metabolic and cardiovascular risk seriously rather than ignore an isolated number. Be plain with yourself about alcohol, since that is the other common driver. A markedly high value, or one that stays high across repeat tests, is worth taking to a hepatologist. Read this enzyme in combination with your other results, not alone.

When Results Can Be Misleading

Several everyday factors can change how you should read the number:

  • Body fat and drinking: more body fat and heavier alcohol use both push levels up strongly. They can raise GGT before a formal liver diagnosis exists.
  • Medications: phenytoin, phenobarbital, carbamazepine, and some other liver-enzyme-inducing drugs can raise the number without meaning new liver damage.
  • Food and coffee: GGT can run lower after meals. Coffee drinkers often have lower values in population studies, but trials have not shown a reliable treatment effect.
  • Acute illness and surgery: a recent operation, heart attack, pancreatitis, or lung-disease flare can lift the number temporarily and independent of chronic liver disease.

Intense exercise, by contrast, does not meaningfully change GGT, so you do not need to skip a workout before the draw.

What Moves This Biomarker

Evidence-backed interventions that affect your GGT level

Increase
Sustained heavy drinking
Heavy drinking raises GGT more than other routine liver tests in many people, and it climbs with the amount you drink. In a Finnish study of nearly 14,000 people, heavy-drinking men and women were about six times as likely to have an abnormal result as non-drinkers, with the rise becoming clear above roughly 14 drinks a week for men and 7 for women. This reflects real strain on liver cells. With abstinence, it takes about two to three weeks for levels to fall by half.
LifestyleStrong Evidence
Decrease
Weight loss from bariatric surgery or structured lifestyle change
Weight loss lowers GGT, and larger weight loss tends to produce larger drops. In weight-loss surgery cohorts of hundreds to nearly 2,000 patients, levels fell substantially within a year. Losing 7 to 10 percent of body weight can improve much of the liver fat and inflammation that drives GGT up, so a falling number often means the liver burden is easing.
LifestyleStrong Evidence
Decrease
Ursodeoxycholic acid
This bile acid medication lowers GGT sharply when it starts high. In a double-blind trial, 600 mg a day for three months cut GGT by about half in people with raised liver enzymes, versus a 10 percent drift down on placebo. It is used for specific bile-flow conditions, not as a general enzyme-lowering supplement.
MedicationStrong Evidence
Decrease
Low-free-sugar diet
Reducing free sugar can lower GGT in people with fatty liver, because sugar can feed liver fat in susceptible people. In an 8-week randomized trial in 40 adolescent boys with fatty liver, a low-free-sugar diet lowered liver fat and dropped GGT from 44 to 33 U/L, while the usual-diet group stayed about the same.
DietModerate Evidence
Decrease
Statin therapy in fatty liver
Statins tend to lower GGT in people with fatty liver rather than raise it, which addresses a common worry about statins and the liver. In mostly before-and-after interventional studies in fatty liver patients, GGT fell by about a quarter. These were not placebo-controlled statin trials, so the finding is strongest as liver-safety evidence, not as proof that statins treat fatty liver.
MedicationModerate Evidence
Decrease
Regular supervised exercise
Exercise can lower GGT in people who start out high, though results are mixed. In a 12-month trial, prediabetic adults with the worst glucose control who trained twice a week dropped about 18 U/L. A separate 12-month trial in fatty liver patients lowered liver fat but did not clearly change GGT. The benefit seems largest when baseline levels are high.
ExerciseModest Evidence
Decrease
L-carnitine supplementation
L-carnitine lowers GGT in some randomized trials, but the effect is inconsistent. Pooling 18 trials in about 1,161 people, levels fell by roughly 9 U/L on average, with bigger drops at doses of 2,000 mg a day or more and courses longer than 12 weeks. A separate analysis limited to fatty liver patients found no clear change. The GGT-specific evidence was rated low certainty.
SupplementModest Evidence

Frequently Asked Questions